Proteomic profiling of human melanoma metastatic cell line secretomes

Journal of Proteome Research

Volumn 10, Issue 10, 2011, Pages 4709-4714

  Rocco, Micaela ^a   Malorni, Livia ^b   Cozzolino, Rosaria ^b   Palmieri, Giuseppe ^c   Rozzo, Carla ^c   Manca, Antonella ^c   Parente, Augusto ^a   Chambery, Angela ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

Author keywords

LC MS; melanoma; metastasis; proteomic profiling; secretome

Indexed keywords

APOLIPOPROTEIN E; B RAF KINASE; BETA 2 MICROGLOBULIN; CHEMOKINE RECEPTOR CXCR4; FIBRONECTIN; GENOMIC DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OSTEOPONTIN; PYRUVATE KINASE; SERUM ALBUMIN; SOMATOMEDIN BINDING PROTEIN 2; VIMENTIN; PROTEOME; TRYPSIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISTANT METASTASIS; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEOMICS; SKIN METASTASIS; CHEMISTRY; CULTURE MEDIUM; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; SKIN TUMOR; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM METASTASIS; PROTEOME; PROTEOMICS; SKIN NEOPLASMS; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 84860481473     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200511f     Document Type: Article

References (67)

1. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100 (1) 57-70 (Pubitemid 30046295)
2. Bissell, M. J.; Radisky, D. Putting tumours in context Nat. Rev. Cancer 2001, 1 (1) 46-54 (Pubitemid 33741880)
3. Tlsty, T. D.; Hein, P. W. Know thy neighbor: stromal cells can contribute oncogenic signals Curr. Opin. Genet. Dev. 2001, 11 (1) 54-9 (Pubitemid 32119278)
4. Langley, R. R.; Fidler, I. J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis Endocr. Rev. 2007, 28 (3) 297-321 (Pubitemid 46984829)
5. Karagiannis, G. S.; Pavlou, M. P.; Diamandis, E. P. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology Mol. Oncol. 2010, 4 (6) 496-510
6. Pavlou, M. P.; Diamandis, E. P. The cancer cell secretome: a good source for discovering biomarkers? J. Proteomics 2010, 73 (10) 1896-906
7. Xue, H.; Lu, B.; Lai, M. The cancer secretome: a reservoir of biomarkers J. Transl. Med. 2008, 6, 52
8. Makridakis, M.; Vlahou, A. Secretome proteomics for discovery of cancer biomarkers J. Proteomics 2010, 73 (12) 2291-305
9. Joyce, J. A.; Pollard, J. W. Microenvironmental regulation of metastasis Nat. Rev. Cancer 2009, 9 (4) 239-52
10. Nguyen, D. X.; Bos, P. D.; Massague, J. Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 2009, 9 (4) 274-84
11. Xue, H.; Lu, B.; Zhang, J.; Wu, M.; Huang, Q.; Wu, Q.; Sheng, H.; Wu, D.; Hu, J.; Lai, M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 2010, 9 (1) 545-55
12. Makridakis, M.; Roubelakis, M. G.; Bitsika, V.; Dimuccio, V.; Samiotaki, M.; Kossida, S.; Panayotou, G.; Coleman, J.; Candiano, G.; Anagnou, N. P.; Vlahou, A. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness J. Proteome Res. 2010, 9 (6) 3243-59
13. Paulitschke, V.; Kunstfeld, R.; Mohr, T.; Slany, A.; Micksche, M.; Drach, J.; Zielinski, C.; Pehamberger, H.; Gerner, C. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells J. Proteome Res. 2009, 8 (5) 2501-10
14. Rondepierre, F.; Bouchon, B.; Bonnet, M.; Moins, N.; Chezal, J. M.; D'Incan, M.; Degoul, F. B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator Melanoma Res. 2010, 20 (2) 77-84
15. Scala, S.; Giuliano, P.; Ascierto, P. A.; Ierano, C.; Franco, R.; Napolitano, M.; Ottaiano, A.; Lombardi, M. L.; Luongo, M.; Simeone, E.; Castiglia, D.; Mauro, F.; De Michele, I.; Calemma, R.; Botti, G.; Caraco, C.; Nicoletti, G.; Satriano, R. A.; Castello, G. Human melanoma metastases express functional CXCR4 Clin. Cancer Res. 2006, 12 (8) 2427-33
16. Illuzzi, G.; Bernacchioni, C.; Aureli, M.; Prioni, S.; Frera, G.; Donati, C.; Valsecchi, M.; Chigorno, V.; Bruni, P.; Sonnino, S.; Prinetti, A. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells J. Biol. Chem. 2010, 285 (24) 18594-602
17. Casula, M.; Muggiano, A.; Cossu, A.; Budroni, M.; Caraco, C.; Ascierto, P. A.; Pagani, E.; Stanganelli, I.; Canzanella, S.; Sini, M.; Palomba, G.; Palmieri, G. Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy BMC Cancer 2009, 9, 352
18. Sini, M. C.; Manca, A.; Cossu, A.; Budroni, M.; Botti, G.; Ascierto, P. A.; Cremona, F.; Muggiano, A.; D'Atri, S.; Casula, M.; Baldinu, P.; Palomba, G.; Lissia, A.; Tanda, F.; Palmieri, G. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma Br. J. Dermatol. 2008, 158 (2) 243-50
19. Chambery, A.; Vissers, J. P.; Langridge, J. I.; Lonardo, E.; Minchiotti, G.; Ruvo, M.; Parente, A. Qualitative and quantitative proteomic profiling of cripto(-/-) embryonic stem cells by means of accurate mass LC-MS analysis J. Proteome Res. 2009, 8 (2) 1047-58
20. Chambery, A.; Severino, V.; D'Aniello, A.; Parente, A. Precursor ion discovery on a hybrid quadrupole-time-of-flight mass spectrometer for gonadotropin-releasing hormone detection in complex biological mixtures Anal. Biochem. 2008, 374 (2) 335-45
21. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4 (3) 207-14 (Pubitemid 46358868)
22. Palagi, P. M.; Walther, D.; Quadroni, M.; Catherinet, S.; Burgess, J.; Zimmermann-Ivol, C. G.; Sanchez, J. C.; Binz, P. A.; Hochstrasser, D. F.; Appel, R. D. MSight: an image analysis software for liquid chromatography-mass spectrometry Proteomics 2005, 5 (9) 2381-4 (Pubitemid 40835407)
23. Severino, V.; Chambery, A.; Vitiello, M.; Cantisani, M.; Galdiero, S.; Galdiero, M.; Malorni, L.; Di Maro, A.; Parente, A. Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7 J. Proteome Res. 2010, 9 (2) 1050-62
24. Mendelsohn, B. A.; Malone, J. P.; Townsend, R.; Gitlin, J. Proteomic analysis of anoxia tolerance in the developing zebrafish embryo Comp. Biochem. Physiol., Part D 2009, 4 (1) 21-31
25. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 2004, 17 (4) 349-56 (Pubitemid 39093515)
26. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340 (4) 783-95 (Pubitemid 38829638)
27. Krogh, A.; Larsson, B.; von Heijne, G.; Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes J. Mol. Biol. 2001, 305 (3) 567-80 (Pubitemid 33032862)
28. Chen, R.; Brentnall, T. A.; Pan, S.; Cooke, K.; Moyes, K. W.; Lane, Z.; Crispin, D. A.; Goodlett, D. R.; Aebersold, R.; Bronner, M. P. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer Mol. Cell. Proteomics 2007, 6 (8) 1331-42 (Pubitemid 47365432)
29. Palmieri, G.; Capone, M.; Ascierto, M. L.; Gentilcore, G.; Stroncek, D. F.; Casula, M.; Sini, M. C.; Palla, M.; Mozzillo, N.; Ascierto, P. A. Main roads to melanoma J. Transl. Med. 2009, 7, 86
30. Curtin, J. A.; Fridlyand, J.; Kageshita, T.; Patel, H. N.; Busam, K. J.; Kutzner, H.; Cho, K. H.; Aiba, S.; Brocker, E. B.; LeBoit, P. E.; Pinkel, D.; Bastian, B. C. Distinct sets of genetic alterations in melanoma N. Engl. J. Med. 2005, 353 (20) 2135-47 (Pubitemid 41653105)
31. Palmieri, G.; Casula, M.; Sini, M. C.; Ascierto, P. A.; Cossu, A. Issues affecting molecular staging in the management of patients with melanoma J. Cell. Mol. Med. 2007, 11 (5) 1052-68 (Pubitemid 350041638)
32. Garraway, L. A.; Widlund, H. R.; Rubin, M. A.; Getz, G.; Berger, A. J.; Ramaswamy, S.; Beroukhim, R.; Milner, D. A.; Granter, S. R.; Du, J.; Lee, C.; Wagner, S. N.; Li, C.; Golub, T. R.; Rimm, D. L.; Meyerson, M. L.; Fisher, D. E.; Sellers, W. R. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 2005, 436 (7047) 117-22 (Pubitemid 40966196)
33. Walter, P.; Gilmore, R.; Blobel, G. Protein translocation across the endoplasmic reticulum Cell 1984, 38 (1) 5-8
34. Mellman, I.; Warren, G. The road taken: past and future foundations of membrane traffic Cell 2000, 100 (1) 99-112 (Pubitemid 30046299)
35. Wang, L.; Yu, J.; Ni, J.; Xu, X. M.; Wang, J.; Ning, H.; Pei, X. F.; Chen, J.; Yang, S.; Underhill, C. B.; Liu, L.; Liekens, J.; Merregaert, J.; Zhang, L. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors Cancer Lett. 2003, 200 (1) 57-67 (Pubitemid 37222359)
36. Han, Z.; Ni, J.; Smits, P.; Underhill, C. B.; Xie, B.; Chen, Y.; Liu, N.; Tylzanowski, P.; Parmelee, D.; Feng, P.; Ding, I.; Gao, F.; Gentz, R.; Huylebroeck, D.; Merregaert, J.; Zhang, L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells FASEB J. 2001, 15 (6) 988-94 (Pubitemid 32290786)
37. Hearing, V.; Leong, S. From Melanocytes to Melanoma. The Progression to Malignancy; Humana Press: New York, 2006; p 678.
38. Brochez, L.; Naeyaert, J. M. Serological markers for melanoma Br. J. Dermatol. 2000, 143 (2) 256-68 (Pubitemid 30650391)
39. Chen, H.; Jia, W. D.; Li, J. S.; Wang, W.; Xu, G. L.; Ma, J. L.; Ren, W. H.; Ge, Y. S.; Yu, J. H.; Liu, W. B.; Zhang, C. H.; Wang, Y. C. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma Med. Oncol. 2010, 10.1007/s12032-010-9763- 1
40. Baker, J. B.; Low, D. A.; Simmer, R. L.; Cunningham, D. D. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells Cell 1980, 21 (1) 37-45 (Pubitemid 10040053)
41. Xu, D.; McKee, C. M.; Cao, Y.; Ding, Y.; Kessler, B. M.; Muschel, R. J. Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1 Cancer Res. 2010, 70 (17) 6988-98
42. Yamashita, T.; Yoneta, A.; Hida, T. Macrophage inhibitory cytokine-1: a new player in melanoma development J. Invest. Dermatol. 2009, 129 (2) 262-4
43. Boyle, G. M.; Pedley, J.; Martyn, A. C.; Banducci, K. J.; Strutton, G. M.; Brown, D. A.; Breit, S. N.; Parsons, P. G. Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity J. Invest. Dermatol. 2009, 129 (2) 383-91
44. Mimeault, M.; Batra, S. K. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer J. Cell. Physiol. 2010, 224 (3) 626-35
45. Ugurel, S.; Bell, N.; Sucker, A.; Zimpfer, A.; Rittgen, W.; Schadendorf, D. Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma Int. J. Cancer 2005, 117 (5) 825-30 (Pubitemid 41598835)
46. Guba, M.; Steinbauer, M.; Ruhland, V.; Schutz, A.; Geissler, E. K.; Anthuber, M.; Vogt, T.; Bosserhoff, A.; Jauch, K. W. Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma Oncol. Rep. 2002, 9 (5) 981-4
47. Fukaya, Y.; Shimada, H.; Wang, L. C.; Zandi, E.; DeClerck, Y. A. Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma J. Biol. Chem. 2008, 283 (27) 18573-81
48. Kim, Y. S.; Jung, J. A.; Kim, H. J.; Ahn, Y. H.; Yoo, J. S.; Oh, S.; Cho, C.; Yoo, H. S.; Ko, J. H. Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase kappa by proprotein convertase 5 Biochem. Biophys. Res. Commun. 2010, 404 (1) 96-102
49. Gaggioli, C.; Robert, G.; Bertolotto, C.; Bailet, O.; Abbe, P.; Spadafora, A.; Bahadoran, P.; Ortonne, J. P.; Baron, V.; Ballotti, R.; Tartare-Deckert, S. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway J. Invest. Dermatol. 2007, 127 (2) 400-10 (Pubitemid 46106920)
50. Prada, F.; Benedetti, L. G.; Bravo, A. I.; Alvarez, M. J.; Carbone, C.; Podhajcer, O. L. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth J. Invest. Dermatol. 2007, 127 (11) 2618-28 (Pubitemid 47585072)
51. Fukunaga-Kalabis, M.; Santiago-Walker, A.; Herlyn, M. Matricellular proteins produced by melanocytes and melanomas: in search for functions Cancer Microenviron. 2008, 1 (1) 93-102
52. Fukunaga-Kalabis, M.; Herlyn, M. Unraveling mysteries of the multifunctional protein SPARC J. Invest. Dermatol. 2007, 127 (11) 2497-8 (Pubitemid 47585075)
53. Podhajcer, O. L.; Benedetti, L. G.; Girotti, M. R.; Prada, F.; Salvatierra, E.; Llera, A. S. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host Cancer Metastasis Rev. 2008, 27 (4) 691-705
54. Robert, G.; Gaggioli, C.; Bailet, O.; Chavey, C.; Abbe, P.; Aberdam, E.; Sabatie, E.; Cano, A.; Garcia de Herreros, A.; Ballotti, R.; Tartare-Deckert, S. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development Cancer Res. 2006, 66 (15) 7516-23 (Pubitemid 44289206)
55. Smit, D. J.; Gardiner, B. B.; Sturm, R. A. Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype Int. J. Cancer 2007, 121 (12) 2653-60 (Pubitemid 350136408)
56. Denhardt, D. T.; Noda, M.; O'Regan, A. W.; Pavlin, D.; Berman, J. S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J. Clin. Invest. 2001, 107 (9) 1055-61 (Pubitemid 32422899)
57. Rangaswami, H.; Bulbule, A.; Kundu, G. C. Osteopontin: role in cell signaling and cancer progression Trends Cell. Biol. 2006, 16 (2) 79-87 (Pubitemid 43247403)
58. Hayashi, C.; Rittling, S.; Hayata, T.; Amagasa, T.; Denhardt, D.; Ezura, Y.; Nakashima, K.; Noda, M. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration J. Cell. Biochem. 2007, 101 (4) 979-86 (Pubitemid 47040877)
59. Sturm, R. A. Osteopontin in melanocytic lesions - a first step towards invasion? J. Invest. Dermatol. 2005, 124 (5) xiv-xv
60. Buback, F.; Renkl, A. C.; Schulz, G.; Weiss, J. M. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology Exp. Dermatol. 2009, 18 (9) 750-9
61. Rangaswami, H.; Kundu, G. C. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways Oncol. Rep. 2007, 18 (4) 909-15
62. Packer, L.; Pavey, S.; Parker, A.; Stark, M.; Johansson, P.; Clarke, B.; Pollock, P.; Ringner, M.; Hayward, N. Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN Carcinogenesis 2006, 27 (9) 1778-86 (Pubitemid 44288660)
63. Zhou, Y.; Dai, D. L.; Martinka, M.; Su, M.; Zhang, Y.; Campos, E. I.; Dorocicz, I.; Tang, L.; Huntsman, D.; Nelson, C.; Ho, V.; Li, G. Osteopontin expression correlates with melanoma invasion J. Invest. Dermatol. 2005, 124 (5) 1044-52 (Pubitemid 40629107)
64. Meierjohann, S.; Schartl, M.; Volff, J. N. Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2004, 138 (3) 281-9 (Pubitemid 39469063)
65. McGary, E. C.; Lev, D. C.; Bar-Eli, M. Cellular adhesion pathways and metastatic potential of human melanoma Cancer Biol. Ther. 2002, 1 (5) 459-65
66. Maung, K.; Easty, D. J.; Hill, S. P.; Bennett, D. C. Requirement for focal adhesion kinase in tumor cell adhesion Oncogene 1999, 18 (48) 6824-8
67. Kahana, O.; Micksche, M.; Witz, I. P.; Yron, I. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma Oncogene 2002, 21 (25) 3969-77 (Pubitemid 34679238)